Abstract
Among antibody classes, IgE has a uniquely slow dissociation rate from, and high affinity for, its cell surface receptor FcɛRI. We show the structural basis for these key determinants of the ability of IgE to mediate allergic hypersensitivity through the 3.4-Å-resolution crystal structure of human IgE-Fc (consisting of the Cɛ2, Cɛ3 and Cɛ4 domains) bound to the extracellular domains of the FcɛRI α chain. Comparison with the structure of free IgE-Fc (reported here at a resolution of 1.9 Å) shows that the antibody, which has a compact, bent structure before receptor engagement, becomes even more acutely bent in the complex. Thermodynamic analysis indicates that the interaction is entropically driven, which explains how the noncontacting Cɛ2 domains, in place of the flexible hinge region of IgG antibodies, contribute together with the conformational changes to the unique binding properties of IgE.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Asher, M.I. et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 368, 733–743 (2006).
Holgate, S. et al. The use of omalizumab in the treatment of severe allergic asthma: A clinical experience update. Respir. Med. 103, 1098–1113 (2009).
Gould, H.J. & Sutton, B.J. IgE in allergy and asthma today. Nat. Rev. Immunol. 8, 205–217 (2008).
Maenaka, K., van der Merwe, P.A., Stuart, D.I., Jones, E.Y. & Sondermann, P. The human low affinity Fcγ receptors IIa, IIb and III bind IgG with fast kinetics and distinct thermodynamic properties. J. Biol. Chem. 276, 44898–44904 (2001).
Gould, H.J. et al. The biology of IgE and the basis of allergic disease. Annu. Rev. Immunol. 21, 579–628 (2003).
Basu, M. et al. Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptor. J. Biol. Chem. 268, 13118–13127 (1993).
Young, R.J. et al. Secretion of recombinant human IgE-Fc by mammalian cells and biological activity of glycosylation site mutants. Protein Eng. 8, 193–199 (1995).
Cook, J.P.D. et al. Identification of contact residues in the IgE binding site of human FcɛRIα. Biochemistry 36, 15579–15588 (1997).
Henry, A.J. et al. Participation of the N-terminal region of Cɛ3 in the binding of human IgE to its high affinity receptor FcɛRI. Biochemistry 36, 15568–15578 (1997).
McDonnell, J.M. et al. The structure of the IgE Cɛ2 domain and its role in stabilizing the complex with its high-affinity receptor FcɛRI. Nat. Struct. Biol. 8, 437–441 (2001).
Zheng, Y., Shopes, B., Holowka, D. & Baird, B. Dynamic conformations compared for IgE and IgG1 in solution and bound to receptors. Biochemistry 31, 7446–7456 (1992).
Beavil, A.J., Young, R.J., Sutton, B.J. & Perkins, S.J. Bent domain structure of recombinant human IgE-Fc in solution by X-ray and neutron scattering in conjunction with an automated curve fitting procedure. Biochemistry 34, 14449–14461 (1995).
Wan, T. et al. The crystal structure of IgE Fc reveals an asymmetrically bent conformation. Nat. Immunol. 3, 681–686 (2002).
Garman, S.C., Wurzburg, B., Tarchevskava, S., Kinet, J.-P. & Jardetzky, T. Structure of the Fc fragment of human IgE bound to its high-affinity receptor FcɛRIα. Nature 406, 259–266 (2000).
Whitty, A. & Kumaravel, G. Between a rock and a hard place. Nat. Chem. Biol. 2, 112–118 (2006).
Garman, S.C., Kinet, J.-P. & Jardetzky, T.S. Crystal structure of the human high-affinity IgE receptor. Cell 95, 951–961 (1998).
Garman, S.C., Sechi, S., Kinet, J.-P. & Jardetzky, T.S. The analysis of the human high affinity IgE receptor FcɛRIα from multiple crystal forms. J. Mol. Biol. 311, 1049–1062 (2001).
Arnold, J.N. et al. The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin. J. Immunol. 173, 6831–6840 (2004).
Sondermann, P., Huber, R., Oosthuizen, V. & Jacob, U. The 3.2Å crystal structure of the human IgG1 Fc fragment–FcγRIII complex. Nature 406, 267–273 (2000).
Radaev, S., Motyka, S., Fridman, W.-H., Sautes-Fridman, C. & Sun, P. The structure of a human type III Fcγ receptor in complex with Fc. J. Biol. Chem. 276, 16469–16477 (2001).
Mirza, O. et al. Dominant epitopes and allergic cross-reactivity: complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1. J. Immunol. 165, 331–338 (2000).
Padavattan, S. et al. Identification of a B-cell epitope of hyaluronidase, a major bee venom allergen, from its crystal structure in complex with a specific Fab. J. Mol. Biol. 368, 742–752 (2007).
Niemi, M. et al. Molecular interactions between a recombinant IgE antibody and the β-lactoglobulin allergen. Structure 15, 1413–1421 (2007).
Li, M. et al. Crystal structure of a dimerized cockroach allergen Bla g 2 complexed with a monoclonal antibody. J. Biol. Chem. 283, 22806–22814 (2008).
Padavattan, S. et al. High-affinity recognition of a conformational epitope of the major respiratory allergen Phl p 2 as revealed by X-ray crystallography. J. Immunol. 182, 2141–2151 (2009).
Rouvinen, J. et al. Transient dimers of allergens. PLoS ONE 5, e9037 (2010).
Roux, K.H., Strelets, L., Brekke, O.H., Sandlie, I. & Michaelsen, T.E. Comparisons of the ability of human IgG3 mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry. J. Immunol. 161, 4083–4090 (1998).
Henry, A.J., McDonnell, J.M., Ghirlando, R., Sutton, B.J. & Gould, H.J. Conformation of the isolated Cɛ3 domain of IgE and its complex with the high-affinity receptor, FcɛRI. Biochemistry 39, 7406–7413 (2000).
Price, N.E., Price, N.C., Kelly, S.M. & McDonnell, J.M. The key role of protein flexibility in modulating IgE interactions. J. Biol. Chem. 280, 2324–2330 (2005).
Dorrington, K.J. & Bennich, H. Thermally induced structural changes in immunoglobulin E. J. Biol. Chem. 248, 8378–8384 (1973).
Demarest, S.J. et al. An intermediate pH unfolding transition abrogates the ability of IgE to interact with its high affinity receptor FcɛRIα. J. Biol. Chem. 281, 30755–30767 (2006).
Wurzburg, B.A., Garman, S.C. & Jardetzky, T.S. Structure of the human IgE-Fc Cɛ3-Cɛ4 reveals conformational flexibility in the antibody effector domains. Immunity 13, 375–385 (2000).
Wurzburg, B.A. & Jardetzky, T.S. Conformational flexibility in immunoglobulin E-Fc3–4 revealed in multiple crystal forms. J. Mol. Biol. 393, 176–190 (2009).
Sondermann, P., Kaiser, J. & Jacob, U. Molecular basis for immune complex recognition: a comparison of Fc-receptor structures. J. Mol. Biol. 309, 737–749 (2001).
McDonnell, J.M. et al. Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor. Nat. Struct. Biol. 3, 419–426 (1996).
Vangelista, L. et al. The immunoglobulin-like modules Cɛ3 and α2 are the minimal units necessary for human IgE-FcɛRI interaction. J. Clin. Invest. 103, 1571–1578 (1999).
Hunt, J. et al. Disulphide linkage controls the affinity and stoichiometry of IgE Fcɛ3–4 binding to FcɛRI. J. Biol. Chem. 280, 16808–16814 (2005).
Hunt, J. et al. Attenuation of IgE affinity for FcɛRI radically reduces the allergic response in vitro and in vivo. J. Biol. Chem. 283, 29882–29887 (2008).
Weiss, M.S. Global indicators of X-ray data quality. J. Appl. Crystallogr. 34, 130–135 (2001).
Nettleship, J.E., Rahman-Huq, N. & Owens, R.J. The production of glycoproteins by transient expression in mammalian cells. Methods Mol. Biol. 498, 245–263 (2009).
Leslie, A.G.W. Recent changes to the MOSFLM package for processing film and image plate data. Joint CCP4 + ESF-EAMCB Newslett. Protein Crystallogr. no. 26 (1992).
Collaborative Computational Project. Number 4. The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D 50, 760–763 (1994).
Vagin, A. & Teplyakov, A. MOLREP: an automated program for molecular replacement. J. Appl. Crystallogr. 30, 1022–1025 (1997).
Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D 60, 2126–2132 (2004).
Brünger, A.T. et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D 54, 905–921 (1998).
Afonine, P.V., Grosse-Kunstleve, R.W. & Adams, P.D. The Phenix refinement framework. CCP4 Newsletter, no. 42, contribution 8 (2005).
Vaguine, A.A., Richelle, J. & Wodak, S.J. SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model. Acta Crystallogr. D 55, 191–205 (1999).
Davis, I.W. et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 35, W375–W383 (2007).
Otwinowski, Z. & Minor, W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276, 307–326 (1997).
Painter, J. & Merritt, E.A. TLSMD web server for the generation of multi-group TLS models. J. Appl. Crystallogr. 39, 109–111 (2006).
Wlodek, S., Skillman, A.G. & Nicholls, A. Automated ligand placement and refinement with a combined force field and shape potential. Acta Crystallogr. D Biol. Crystallogr. 62, 741–749 (2006).
Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797 (2007).
Pettersen, E.F. et al. UCSF Chimera—a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
Hayward, S. & Berendsen, J.C. Systematic analysis of domain motions in proteins from conformational change; new research on citrate synthase and T4 lysozyme. Proteins 30, 144–154 (1998).
Hayward, S. & Lee, R.A. Improvements in the analysis of domain motions in proteins from conformational change: DynDom version 1.50. J. Mol. Graph. Model. 21, 181–183 (2002).
Hodis, E., Schreiber, G., Rother, K. & Sussman, J.L. eMovie: a storyboard-based tool for making molecular movies. Trends Biochem. Sci. 32, 199–204 (2007).
Myszka, D.G. Improving biosensor analysis. J. Mol. Recognit. 12, 279–284 (1999).
Acknowledgements
We thank N. Rahman for assistance with receptor protein production (Oxford Protein Production Facility), T. Walter for technical advice on crystallization of the complex, and K. Harlos and C. Siebold (Division of Structural Biology, Wellcome Trust Centre for Human Genetics) for X-ray data collection of the complex, together with beamline support staff at European Synchrotron Radiation Facility. This work was also carried out with the support of the Diamond Light Source. The work was funded by Asthma UK and the UK Medical Research Council.
Author information
Authors and Affiliations
Contributions
M.D.H. and A.M.D. carried out the crystallographic analysis of the complex, and B.D. the crystallographic analysis of IgE-Fc; M.D.H., J.E.N., J.H., A.J.B. and R.J.O. produced the proteins; S.C.B. and J.M.M. carried out the thermodynamic analysis; E.G. contributed to the analysis of the conformational changes; H.J.G., A.J.B. and B.J.S. planned and directed the project; M.D.H., A.M.D., J.M.M. and B.J.S. wrote the paper.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–6 (PDF 706 kb)
Supplementary Video 1
Overall structure of the IgE-Fc/sFcɛRIα complex. This video shows the proposed orientation of the complex in relation to the cell membrane and highlights the acute bend in IgE-Fc, with the Cɛ2 domains packed against the Cɛ3 and Cɛ4 domains. The complex is rotated by 90° clockwise, 180° anti-clockwise, and 90° clockwise about an axis orthogonal to the cell membrane. IgE-Fc chains A and B are colored in green and purple respectively, and sFcɛRIα in yellow. (MOV 2938 kb)
Supplementary Video 2
Conformational change in IgE-Fc. This video demonstrates the conformational change that takes place in IgE-Fc upon sFcɛRIα binding. The video shows the same conformational change from four views, each 90° apart. The change is demonstrated by morphing the free structure of IgE-Fc into that of the receptor-bound form, and then back to the free form. IgE-Fc chains A and B are colored in green and purple, respectively. (MOV 11684 kb)
Supplementary Video 3
Conformational change in Cɛ2 and Cɛ3 domains on receptor binding. This video demonstrates the conformational change that takes place in IgE-Fc upon sFcɛRIα binding (with emphasis on the Cɛ2 domains), and shows how the Cɛ2A, Cɛ2B and Cɛ3A domains move together as a rigid unit. The video also shows the small conformational change within Cɛ3B. The free structure of IgE-Fc is first shown, and then morphed into the receptor-bound form. The receptor is briefly displayed, after which IgE-Fc is morphed back to the free form. IgE-Fc chains A and B are colored in green and purple respectively, and sFcɛRIα in yellow. (MOV 2149 kb)
Rights and permissions
About this article
Cite this article
Holdom, M., Davies, A., Nettleship, J. et al. Conformational changes in IgE contribute to its uniquely slow dissociation rate from receptor FcɛRI. Nat Struct Mol Biol 18, 571–576 (2011). https://doi.org/10.1038/nsmb.2044
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nsmb.2044
This article is cited by
-
The mechanistic and functional profile of the therapeutic anti-IgE antibody ligelizumab differs from omalizumab
Nature Communications (2020)
-
Component analysis and antiasthmatic effects of Huashanshen dripping pill
Medicinal Chemistry Research (2020)
-
Cytoskeletal actin patterns shape mast cell activation
Communications Biology (2019)
-
Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody
Scientific Reports (2018)
-
Trapping IgE in a closed conformation by mimicking CD23 binding prevents and disrupts FcεRI interaction
Nature Communications (2018)